Headache: Definition, Causes, Workup, and Management
Definition
Headache is pain or discomfort in the head or face region, classified as either primary (no underlying pathology—migraine, tension-type, cluster) or secondary (caused by an underlying medical condition such as vascular, neoplastic, infectious, or intracranial pressure abnormalities). 1, 2
Causes
Primary Headache Disorders
Tension-type headache is the most common primary headache disorder, affecting approximately 38% of the general population. 1, 2
Migraine without aura: Recurrent moderate-to-severe unilateral, pulsating headache lasting 4-72 hours with nausea/vomiting, photophobia, and phonophobia; worsens with routine activity. 3, 1
Migraine with aura: Same features as migraine without aura plus recurrent, short-lasting visual and/or hemisensory disturbances that precede or accompany the headache. 3, 1
Chronic migraine: ≥15 headache days per month for >3 months, with ≥8 days meeting migraine criteria. 3, 1
Tension-type headache: Bilateral, mild-to-moderate pressing/tightening quality; lacks migraine features (no nausea/vomiting, no photophobia plus phonophobia); not aggravated by routine activity. 1, 4
Cluster headache: Strictly unilateral severe headache lasting 15-180 minutes with ipsilateral autonomic symptoms (lacrimation, conjunctival injection, nasal congestion, ptosis, miosis); prevalence approximately 0.1% of the population. 1, 4
Secondary Headache Disorders (Red Flags)
Any patient presenting with red flag features requires immediate evaluation for life-threatening secondary causes before considering primary headache disorders. 4, 5
Subarachnoid hemorrhage: Thunderclap headache ("worst headache of life"), may have altered taste sensation. 1, 4
Meningitis: Headache with neck stiffness and unexplained fever—a life-threatening condition requiring immediate evaluation. 1, 4
Brain tumor/space-occupying lesion: Progressive headache, awakens from sleep, worsens with Valsalva/cough. 1, 4
Giant cell arteritis: New-onset headache in patients >50 years with scalp tenderness, jaw claudication. 1
Stroke/TIA: Atypical aura with focal neurological symptoms. 1
Increased intracranial pressure: Headache worsening with coughing, sneezing, exercise. 1
Medication-overuse headache: ≥15 headache days/month with regular overuse of acute medications (non-opioid analgesics ≥15 days/month or other acute medications ≥10 days/month) for >3 months. 1
Spontaneous intracranial hypotension: Orthostatic headache (absent/mild on waking, onset within 2 hours of upright posture, >50% improvement within 2 hours of lying flat). 1
Workup
History
The medical history is the mainstay of headache diagnosis; a detailed history enables systematic application of the International Classification of Headache Disorders-3 (ICHD-3) criteria. 3, 6
An adequate medical history must include:
Age at onset: Migraine typically begins at or around puberty; new-onset headache after age 50 is a red flag. 3, 1, 4
Duration of episodes: Migraine 4-72 hours; cluster 15-180 minutes; tension-type variable. 1
Frequency: Episodic vs chronic (≥15 days/month). 1
Pain location: Unilateral (migraine, cluster) vs bilateral (tension-type). 1
Pain quality: Pulsating (migraine) vs pressing/tightening (tension-type) vs severe unilateral (cluster). 1
Pain severity: Moderate-to-severe (migraine, cluster) vs mild-to-moderate (tension-type). 1
Aggravating factors: Routine activity worsens migraine but not tension-type; Valsalva/cough suggests secondary causes. 1, 4
Relieving factors: Lying flat improves orthostatic headache. 1
Accompanying symptoms: Nausea/vomiting, photophobia, phonophobia (migraine); autonomic symptoms (cluster). 3, 1
Aura symptoms: Visual/hemisensory disturbances lasting <60 minutes. 1
Medication use: Acute and preventive medication history for medication-overuse headache. 3, 1
Family history: Migraine has a strong genetic component; family history strengthens suspicion. 3, 1
Red Flags Requiring Urgent Investigation
The presence of any red flag mandates immediate evaluation for secondary causes before diagnosing a primary headache disorder. 4, 5
- Thunderclap headache 1, 4
- New-onset headache after age 50 1, 4
- Progressive worsening headache 1, 4
- Atypical aura (focal neurological symptoms or duration >60 minutes) 1
- Recent head/neck trauma 1, 4
- Headache awakening patient from sleep 1, 4
- Headache brought on by Valsalva, cough, or exertion 1, 4
- Focal neurological symptoms/signs 1, 4
- Unexplained fever with neck stiffness or limited neck flexion 1, 4
- Altered consciousness, memory, or personality 1
- Witnessed loss of consciousness 1
Physical Examination
Physical examination is most often confirmatory; a normal neurological examination yields a low probability (0.2%) of finding serious intracranial pathology in migraine patients. 3, 1
- Perform a thorough neurological examination to identify any focal deficits. 3, 4
- Check for neck stiffness and fever (meningitis). 1, 4
- Assess for scalp tenderness and jaw claudication in patients >50 years (giant cell arteritis). 1
Diagnostic Aids
Headache diaries are essential for accurate diagnosis, reducing recall bias and allowing systematic application of ICHD-3 criteria over multiple attacks. 3, 6, 4
Headache diary: Document frequency, duration, character, triggers, accompanying symptoms, medication use. 3, 1, 6
ID-Migraine questionnaire (3-item): Sensitivity 0.81, specificity 0.75, positive predictive value 0.93. 1, 6
Migraine Screen Questionnaire (5-item): Sensitivity 0.93, specificity 0.81, positive predictive value 0.83. 1, 6
Investigations
Investigations are only indicated when red flags suggest secondary causes; neuroimaging should not be performed routinely for primary headache disorders with a normal neurological examination. 6, 4
MRI brain with and without contrast: Preferred modality for subacute presentations or suspected tumor/inflammatory process; higher resolution, no ionizing radiation. 1, 4
Non-contrast CT head: If presenting <6 hours from acute severe headache onset (subarachnoid hemorrhage); sensitivity 95% on day 0,74% on day 3,50% at 1 week. 1
CT head: Acute trauma or abrupt-onset headache. 1
ESR/CRP: If temporal arteritis suspected (patients >50 years with new-onset headache); note ESR can be normal in 10-36% of giant cell arteritis cases. 1
Lumbar puncture: Occasionally required to confirm or reject suspicions of secondary causes (meningitis, subarachnoid hemorrhage if CT negative). 3
Management
Acute Treatment of Migraine
NSAIDs or acetaminophen are first-line for mild-to-moderate migraine attacks. 3, 2
Triptans or ergot derivatives: For moderate-to-severe migraine attacks or when NSAIDs fail; triptans eliminate pain in 20-30% of patients by 2 hours but cause transient flushing, tightness, or tingling in 25% of patients. 3, 2
- Contraindication: Patients with or at high risk for cardiovascular disease should avoid triptans due to vasoconstrictive properties. 2
Gepants (rimegepant, ubrogepant): Calcitonin gene-related peptide receptor antagonists; eliminate headache in 20% of patients at 2 hours with adverse effects of nausea and dry mouth in 1-4% of patients. 2
Lasmiditan (5-HT1F agonist): Available for acute migraine treatment and appears safe in patients with cardiovascular risk factors. 2
Antiemetics: For nausea/vomiting. 3
Acute Treatment of Cluster Headache
High-flow oxygen (100% at 12-15 L/min) is first-line acute treatment for cluster headache. 1
- Subcutaneous or intranasal triptans: Alternative acute treatment for cluster headache. 1
Preventive Treatment of Migraine
Preventive treatments reduce migraine by 1-3 days per month relative to placebo and should be considered for patients with chronic migraine or frequent episodic migraine. 3, 2
First-line preventive medications include:
- Beta-blockers (propranolol): 80-240 mg oral daily. 3
- Anticonvulsants (topiramate): 50-100 mg oral daily. 3
Second-line preventive medications include:
- Amitriptyline: 10-100 mg oral at night; recommended as first-line for tension-type headache prophylaxis. 3
- Flunarizine: 5-10 mg oral once daily. 3
Third-line preventive medications include:
- OnabotulinumtoxinA: 155-195 units to 31-39 sites every 12 weeks. 3
- Calcitonin gene-related peptide monoclonal antibodies (erenumab, fremanezumab, eptinezumab): Monthly or quarterly dosing. 3, 2
Referral Criteria
Emergency admission is indicated for any red flag present or patient unable to self-care without help. 1, 4
Urgent referral to neurology (within 48 hours): Suspected spontaneous intracranial hypotension, patient unable to self-care but has help. 1
Routine referral to neurology (2-4 weeks): Suspected primary headache disorder, diagnosis uncertain, first-line treatments fail. 1
Referral to rheumatology: Suspected giant cell arteritis. 1
Common Pitfalls
Medication-overuse headache: Headache on ≥15 days/month with regular overuse of non-opioid analgesics on ≥15 days/month for ≥3 months, or any other acute medication on ≥10 days/month for ≥3 months, rules out simple episodic migraine and requires withdrawal of overused medications. 1
Chronic migraine misdiagnosis: ≥15 headache days/month for >3 months, with ≥8 days meeting migraine criteria, represents chronic migraine—a distinct entity requiring preventive therapy, not just acute treatment. 1
Failure to recognize red flags: Always assess for red flags before diagnosing a primary headache disorder; missing a secondary cause can result in significant morbidity and mortality. 4, 5